The limitation of flowcytometry is ignored in the assessment of antimitochondrial antibodies in rheumatoid arthritis: comment on the article by Moore et al. | Arthritis Rheumatol;76(3): 488-489, 2024 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

The limitation of flowcytometry is ignored in the assessment of antimitochondrial antibodies in rheumatoid arthritis: comment on the article by Moore et al.

Jearn, La-He; Kim, Think-You.

Affiliation

Jearn LH; Hanyang University Medical Center, Seongdong-gu, Seoul, Republic of Korea.
Kim TY; Hanyang University College of Medicine, Seongdong-gu, Seoul, Republic of Korea.

Arthritis Rheumatol ; 76(3): 488-489, 2024 Mar.

Article in En | MEDLINE | ID: mdl-37818724

Subject(s)

Arthritis, Rheumatoid; Humans; Antibodies

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2024 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid Limits: Humans Language: En Journal: Arthritis Rheumatol Year: 2024 Document type: Article Country of publication: United States